[Editors' Choice] CRISPR cuts disease course short in blood disorders

Gene editing for sickle cell disease and β-thalassemia results in potential curative response.

Source: Science Translational Medicine - January 6, 2021 Category: Biomedical Science Authors: György, B. Tags: Editors ' Choice Source Type: research